Introduction
Methods
Patients
The Nephronophthisis Registry
Genetic analyses
Statistical analyses
Results
Phenotypic variability in renal ciliopathies
Gene | Patients | Families | Median age (range)a (years) | Visual impairmentb | Oculomotor abnormalities | Developmental delay | Liver abnormalities | Congenital heart defect | Narrow thorax | Polydactyly | Obesity |
---|---|---|---|---|---|---|---|---|---|---|---|
NPHP1
| n = 16 | n = 14 | 21 (9–62) | 19% (3/16) | 7% (1/14) | 7% (1/14) | 0% (0/8) | 8% (1/13) | 0% (0/14) | 0% (0/14) | 13% (2/16) |
NPHP4
| n = 3 | n = 3 | 19 (11–41) | 0% (0/3) | 0% (0/3) | 0% (0/3) | 0% (0/1) | 0% (0/2) | 0% (0/1) | 0% (0/2) | 0% (0/3) |
WDR35
| n = 3 | n = 2 | 17 (12–33) | 33% (1/3) | 33% (1/3) | 0% (0/3) | 50% (1/2) | 0% (0/3) | 67% (2/3) | 33% (1/3) | 33% (1/3) |
BBS1
| n = 2 | n = 1 | 18 (16–20) | 100% (2/2) | 0% (0/1) | 100% (2/2) | 0% (0/0) | 0% (0/0) | 0% (0/2) | 0% (0/2) | 100% (2/2) |
AHI1
| n = 1 | n = 1 | 25 | 100% (1/1) | 100% (1/1) | 100% (1/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) |
BBS10
| n = 1 | n = 1 | 13 | 100% (1/1) | NA | 100% (1/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) | 100% (1/1) | 100% (1/1) |
IQCB1
| n = 1 | n = 1 | 29 | 100% (1/1) | 100% (1/1) | 0% (0/1) | NA | NA | 0% (0/1) | 0% (0/1) | 0% (0/1) |
OFD1
| n = 1 | n = 1 | 12 | 0% (0/1) | 100% (1/1) | 100% (1/1) | NA | 0% (0/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) |
Unknownc | n = 12 | n = 12 | 21 (15–54) | 58% (7/12) | 56% (5/9) | 70% (7/10) | 44% (4/9) | 20% (1/5) | 0% (0/6) | 29% (2/7) | 33% (3/9) |
Total | n = 40 | n = 36 | 19 (9–62) | 40% (16/40) | 30% (10/33) | 36% (13/36) | 23% (5/22) | 8% (2/26) | 7% (2/30) | 13% (4/32) | 24% (9/37) |
Fatigue and polyuria are presenting symptoms of NPH
Increased echogenicity is a more prevalent finding than renal cysts in NPH-RC
Gene | Patients | Families | Median age (range)a (years) | Median age symptom onset (range)a(years) | Median age ESRD (range)a(years) | Median time to ESRD (range)a,b(years) | Polyuria | Polydipsia | Enuresis | Renal ultrasound findings | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cysts | Abnormal corticomedullary differentiation | Increased echogenicity | ||||||||||
NPHP1
| n = 16 | n = 14 | 21 (9–62) | 9 (6–26) | 14 (7–28) | 1 (0–8) | 90% (9/10) | 80% (8/10) | 38% (3/8) | 33% (4/12) | 38% (3/8) | 70% (7/10) |
NPHP4
| n = 3 | n = 3 | 19 (11–41) | 16 (8–24) | 8 | 0 | 33% (1/3) | 67% (2/3) | 0% (0/3) | 50% (1/2) | 50% (1/2) | 100% (2/2) |
WDR35
| n = 3 | n = 2 | 17 (12–33) | 9 | 12 | 3 | 67% (2/3) | 50% (1/2) | 0% (0/2) | 67% (2/3) | 33% (1/3) | 100% (2/2) |
BBS1
| n = 2 | n = 1 | 18 (16–20) | NA | – | NA | 0% (0/1) | 0% (0/1) | 0% (0/1) | 50% (1/2) | 0% (0/2) | 0% (0/2) |
AHI1
| n = 1 | n = 1 | 25 | 14 | – | NA | 0% (0/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) | 0% (0/1) |
BBS10
| n = 1 | n = 1 | 13 | NA | – | NA | 100% (1/1) | 100% (1/1) | 0% (0/1) | 100% (1/1) | 100% (1/1) | 100% (1/1) |
IQCB1
| n = 1 | n = 1 | 29 | NA | 10 | NA | NA | NA | NA | NA | NA | NA |
OFD1
| n = 1 | n = 1 | 12 | 5 | 5 | 0 | NA | NA | NA | 0% (0/1) | 0% (0/1) | 100% (1/1) |
Unknown | n = 12 | n = 12 | 21 (15–54) | 13 (5–33) | 14 (8–47) | 11 (8–14) | 33% (2/6) | 86% (6/7) | 33% (1/3) | 50% (4/8) | 17% (1/6) | 57% (4/7) |
Total | n = 40 | n = 36 | 19 (9–62) | 9 (5–33) | 13 (5–47) | 1 (0–14) | 60% (15/25) | 72% (18/25) | 21% (4/19) | 43% (13/30) | 32% (7/22) | 65% (17/26) |
Histological findings are frequently nonspecific in NPH
NPHP1 mutations in 38% of tested patients
ID | Gene | Zygosity | Accession no. | c.Position | p.Position | HGMD accession | Polyphen-2 | Mut Tast | SIFT | Gerp | ExACa | Clinical diagnosis |
---|---|---|---|---|---|---|---|---|---|---|---|---|
6:39 |
NPHP1
| Hom | NM_000272.3 | c.1-?_2034+?del | p.(?) | NA | NA | NA | NA | NA | NA | NPH |
24:60 |
NPHP1
| Hom | NM_000272.3 | c.1-?_2034+?del | p.(?) | NA | NA | NA | NA | NA | NA | NPH |
9:42 9:43 |
NPHP1
| Comp het | NM_000272.3 | c.1-?_2034+?del; | p.(?) | NA | NA | NA | NA | NA | NA | NPH |
c.1039C>T | p.Arg347* | CM080456 | NA | DC | NA | NA | NA | |||||
11:45 |
NPHP1
| Comp het | NM_000272.3 | Deletion; | p.(?); | NA | NA | NA | NA | NA | NA | SLS |
c.1027G>A | p.Gly343Arg | CM066932 | Probably damaging | DC | NA | 5.79 | 13/0/119452 | |||||
23:58 |
TMEM67
| Comp het | NM_153704.5 | c.870-5delb; | p.(?) | NA | NA | NA | NA | NA | NA | Other (BBS-like) |
c.1379G>C | p.Arg460Thr | NA | Benign | DC | NA | NA | 36/0/120958 | |||||
1:34 |
TMEM67
| Comp het | NM_153704.5 | c.1843T>C; | p.Cys615Arg; | CM094694 | Possibly damaging | DC | Deleterious | 4.16 | 29/0/121374 | JBTS |
c.628T>C | p.Ser210Pro | NA | Benign | P | Tolerated | 4.45 | 1/0/121256 | |||||
IQCB1
| Het | NM_001023571.2 | c.59delA | NA | NA | NA | NA | NA | 4.45 | NA | ||
5:38 |
TMEM67
| Comp het | NM_153704.5 | c.2498T>C; | p.Ile833Thr | CM090682 | Probably damaging | DC | Deleterious | 3.49 | 4/0/121114 | JBTS |
c.628T>C | p.Ser210Pro | NA | Benign | P | Tolerated | 4.45 | 1/0/121256 | |||||
3:36 |
CEP290
| Het | NM_025114.3 | c.6320A>G | p.Lys2107Arg | NA | Probably damaging | DC | Tolerated | 4.65 | 2/0/56244 | JBTS |
KIF7
| Het | NM_198525.2 | c.505C>T | p.Arg169Trp | Probably damaging | DC | Deleterious | 3.42 | 1/0/21750 | |||
2:35 |
CEP164
| Het | NM_014956.4 | c.151C>T | p.Arg51* | NA | NA | DC | NA | 2.37 | 2/0/106462 | JBTS |
29:65 |
NINL
| Het | NM_025176.5 | c.1318G>C | p.Glu440Gln | NA | Probably damaging | DC | Damaging | 4.6 | NA | NPH |
4:37 | NA | JBTS | ||||||||||
10:44 | NA | NPH |